Difference between revisions of "Part:BBa K2549004"

 
Line 3: Line 3:
 
<partinfo>BBa_K2549004 short</partinfo>
 
<partinfo>BBa_K2549004 short</partinfo>
  
Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP.
+
Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP[1]. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 12: Line 12:
 
<partinfo>BBa_K2549004 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K2549004 SequenceAndFeatures</partinfo>
  
 +
===References===
 +
[1]A robust pipeline for rapid production of versatile nanobody repertoires. Fridy PC, Li Y, Keegan S, ..., Chait BT, Rout MP. Nat Methods, 2014 Dec;11(12):1253-60 PMID: 25362362; DOI: 10.1038/nmeth.3170
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  

Revision as of 11:31, 6 October 2018


anti-GFP (LaG17)

Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP[1]. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 34

References

[1]A robust pipeline for rapid production of versatile nanobody repertoires. Fridy PC, Li Y, Keegan S, ..., Chait BT, Rout MP. Nat Methods, 2014 Dec;11(12):1253-60 PMID: 25362362; DOI: 10.1038/nmeth.3170